| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2004008837A2 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them |
| 01/29/2004 | WO2003053971A8 Pyridoquinoxaline antivirals |
| 01/29/2004 | WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019068 Nitrogen compounds such as 2-(5-formylamino-6-oxo-2-phenyl-1,6 -dihydropyrimidin-1-yl)-N-(2,3-dioxo-1-phenylmethyl-6-(2 -pyridyloxy))hexylacetamide used for prophylaxis cardiovascular disorders; restenosis |
| 01/29/2004 | US20040019067 Kinase inhibitors |
| 01/29/2004 | US20040019049 Substituted quinazolinone compounds |
| 01/29/2004 | US20040019037 E.g.,((5-(2,4-Diaminopyrimidin-6-yl)pentanoyl)-(N-methyl)amino )-3-(6-meth-oxypyridin-3-yl)-propanoic acid, inhibition of bone resorption, restenosis, angiogenesis inhibitors, antiarthritic, -tumor, -carcinogenic agents; antidiabetic |
| 01/29/2004 | US20040019017 Caspase inhibitor prodrugs |
| 01/29/2004 | US20040018942 Herbicides; controlling weeds |
| 01/29/2004 | US20040016906 Difluoromethyl ether derivative and process for producing the same |
| 01/29/2004 | US20040016063 1,3-Dihydroxybenzene derivatives and colorants containing said compounds |
| 01/29/2004 | CA2493457A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | CA2492906A1 Materials and methods for treating hypercholesterolemia |
| 01/29/2004 | CA2492217A1 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them |
| 01/28/2004 | EP1384712A1 Derivatives of N-((quinolinyl)oxy)-phenyl)-urea and N-((quinazolinyl)oxy)-phenyl)-urea with antitumor activity |
| 01/28/2004 | EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors |
| 01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 01/28/2004 | EP1383746A2 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | EP0794947B1 N-substituted hydrazinophenylsulphonyl ureas used as herbicides and plant-growth regulators |
| 01/28/2004 | CN1136216C Pyrone carboxy Lic acid derivative or lts salt and antibiotic with the same us effective component |
| 01/28/2004 | CN1136199C Process for preparing alpha-adrenergic receptor antagonist |
| 01/28/2004 | CN1136198C Novel benzyl pyrimidines |
| 01/28/2004 | CN1136193C Imide derivatives ar Salts thereof |
| 01/28/2004 | CN1136192C Aryl and hetaryl-sulfonamide derivatives, their preparation and use as endo thelin antagonists |
| 01/27/2004 | US6683648 Enzyme inhibitors such as 2s-(((dimethylamino)acetyl)amino)-n-(3-((((2-hydroxy-1,1 -dimethylethyl)amino)sulfonyl)(3-methyl butyl)amino)-2r-hydroxy-1s-(phenylmethyl)-propyl)-3,3-dimethyl butanamide, used for prohylaxis of viral diseases |
| 01/27/2004 | US6683211 Fungicides for crops |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683192 Substituted benzo(b)thien compounds useful for modulating proliferation or differentiation of a cell, agonizes hedgehog mediated signal trasnduction with an ed50 of 1mm or less |
| 01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/27/2004 | US6683086 Ultrashort acting hypnotic barbiturates |
| 01/27/2004 | US6683029 Halopyrimidines |
| 01/27/2004 | US6682661 Electrooptical liquid crystal system |
| 01/27/2004 | CA2062387C Process for the preparation of sulfonylureas |
| 01/22/2004 | WO2004007471A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 01/22/2004 | WO2004007469A1 New alkynylated quinazolin compounds as mmp-13 inhibitors |
| 01/22/2004 | WO2004007467A1 Novel 3-(3-[aminosulfonylamino]-4-cyano-phenyl)-6-trifluoromethyl-uracils |
| 01/22/2004 | WO2004007466A1 Method for producing highly pure crystalline 4-amino-5,6-dimethoxypyrimidine |
| 01/22/2004 | WO2004007437A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | WO2004006927A2 Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors |
| 01/22/2004 | WO2004006878A1 Merocyanine derivatives for cosmetic use |
| 01/22/2004 | WO2004006846A2 Receptor-type kinase modulators and methods of use |
| 01/22/2004 | WO2003099231A3 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 01/22/2004 | WO2003080545A3 Substituted phenylacetic acids |
| 01/22/2004 | WO2003026570A3 Reduced toxicity cisplatin formulations and methods for using the same |
| 01/22/2004 | US20040015037 Radioactive member and method of making |
| 01/22/2004 | US20040014968 Such as 2-(3-chloro-phenyl)-3-cyclopentyl-N-thiazol-2-yl-propionamide which increases insulin secretion in treatment of type II diabetes |
| 01/22/2004 | US20040014784 Substituted propargylamines |
| 01/22/2004 | US20040014774 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| 01/22/2004 | US20040014767 Central nervous system diosrders; antidepressants, anxiolytic agents, anxiolytic agents |
| 01/22/2004 | US20040014765 Chk-1 inhibitors |
| 01/22/2004 | US20040014744 Anticancer, antitumor agents |
| 01/22/2004 | DE10231711A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 01/22/2004 | DE10228183A1 3,3,4,4-Tetrafluorcyclopentanverbindungen 3,3,4,4-tetrafluoroethane cyclopentadiene compounds |
| 01/22/2004 | CA2493373A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | CA2492251A1 Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors |
| 01/22/2004 | CA2491191A1 Receptor-type kinase modulators and methods of use |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP1381392A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 01/21/2004 | EP1305028A4 Antimicrobial biaryl compounds |
| 01/21/2004 | EP0937048B1 HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa |
| 01/21/2004 | EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists |
| 01/21/2004 | CN1469916A C-nitrosoaniline compounds and their blends as polymerization inhibitors |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469867A Novel phenylalanine derivatives |
| 01/21/2004 | CN1469866A New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication |
| 01/21/2004 | CN1469862A 2,2-diphenyl butanamide derivatives and medicines containing the same |
| 01/21/2004 | CN1135228C N-aryloxyethyl-indoly-alkylamines for treatment of depression |
| 01/21/2004 | CN1135227C 2,6-twice substituted pyridine and 2,4 twice substituted pyrimidine for berbicide |
| 01/20/2004 | US6680323 Dihydropyrimidines and uses thereof |
| 01/20/2004 | US6680303 3′,5-difluoro-2′,3′-didehydropyrimidine nucleosides and methods of treatment therewith |
| 01/20/2004 | CA2284795C Novel pyrimidine derivatives and processes for the preparation thereof |
| 01/20/2004 | CA2204039C 2-[(2-alkoxy-6-trifluoromethyl pyrimidine-4-yl)-oxymethylene]-phenyl-acetic acid derivatives, processes and intermediate products for their production and their use |
| 01/15/2004 | WO2004005513A2 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 01/15/2004 | WO2004005265A1 Quinazoline derivatives |
| 01/15/2004 | WO2004004652A2 Mitotic kinesin binding site |
| 01/15/2004 | WO2003084936A8 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 01/15/2004 | WO2003066060A3 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
| 01/15/2004 | US20040009997 Treating diseases in which HMG CoA reductase is implicated, such as hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 01/15/2004 | US20040009991 Calcium channel antagonistic activity; especially useful as analgesics |
| 01/15/2004 | US20040009988 Inhibiting hepatic production of apoprotein B-100 and microsomal triglyceride transfer protein to decrease VLDL and chylomicrons production |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/15/2004 | US20040009975 Useful for the treatment of inflammation and immunological diseases. |
| 01/15/2004 | US20040009122 A formulation V-L-R where v is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker or a bond and R is a detectable moiety (v is nonpeptidic or peptide and R is a macromolecule) |
| 01/15/2004 | CA2490579A1 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 01/15/2004 | CA2489562A1 Mitotic kinesin binding site |
| 01/15/2004 | CA2489251A1 Quinazoline derivatives |
| 01/14/2004 | EP1379517A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 01/14/2004 | EP1379510A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 01/14/2004 | EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/14/2004 | EP1222195B1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 01/14/2004 | CN1468232A Heterocyclic sodium/proton exchange inhibitors and method |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468225A 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |